{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:41:16Z","timestamp":1784245276489,"version":"3.55.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:p>\n                    The treatment effect of sodium bicarbonate in diabetic ketoacidosis (DKA) remains controversial, as clinical guidelines recommend its use only in extreme acidemia (pH\u2005&lt;\u20056.9) owing to inconsistent evidence and concerns over potential risks such as paradoxical central nervous system acidosis, delayed ketone clearance, and electrolyte imbalance. This study aimed to evaluate the real-world effectiveness and safety of sodium bicarbonate therapy in critically ill patients with DKA in a large clinical database. This is a retrospective cohort study following the STROBE guidelines on the MIMIC-IV database. The propensity score matching was used to balance the baseline difference. The primary outcome was the risk of multiple organ dysfunction syndrome (MODS). Secondary outcomes were the risk of renal function worsening, and neurological worsening. Adverse events included mortality, hospital readmission, and the occurrence of posttreatment supplementation of potassium or calcium. The Cox regression along with the marginal structural Cox model was employed to analyze the internal time-varying covariates. A total of 482 patients after propensity score matching was included. The Cox regression reveals that sodium bicarbonate (NaHCO\n                    <jats:sub>3<\/jats:sub>\n                    ) use was associated with a lower risk of MODS, renal worsening, and neural worsening, while marginal structural Cox model also proved a lower risk in the creatinine exceeding (hazards ratio: 0.36, 95% confidence interval: 0.25\u20130.52,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05) and Glasgow Coma Scale worsening (hazards ratio: 0.36, 95% confidence interval: 0.18\u20130.75,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). No statistically significant association was found between NaHCO\n                    <jats:sub>3<\/jats:sub>\n                    use and mortality, readmission, or posttreatment of potassium or calcium, but potential adverse effect of NaHCO\n                    <jats:sub>3<\/jats:sub>\n                    use on MODS or readmission was detected in the severe subgroups. Sodium bicarbonate showed a potential protective association with MODS, neurological function protection, and was associated with modest protection in renal function among patients with DKA. Its use did not appear to significantly increase the risk of mortality, readmission, or posttreatment electrolyte supplementation. However, a possible adverse association with MODS and readmission was observed in the most severe subgroups. In all, NaHCO\n                    <jats:sub>3<\/jats:sub>\n                    in DKA patients still need cautious patient selection and close monitoring of fluid and biochemical status during therapy.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047529","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T17:01:52Z","timestamp":1769965312000},"page":"e47529","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic effectiveness of sodium bicarbonate in diabetic ketoacidosis: A retrospective cohort analysis using the marginal structural Cox model"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4284-9750","authenticated-orcid":false,"given":"Xiaoyu","family":"Wu","sequence":"first","affiliation":[{"name":"The First Clinical College of Medicine, Nanjing Medical University, Nanjing, China"},{"name":"Affiliated Wuxi Peoples Hospital, Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejim.2023.07.005","article-title":"Management of diabetic ketoacidosis.","volume":"117","author":"Barski","year":"2023","journal-title":"Eur J Intern Med"},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMra1207788","article-title":"Acid-base problems in diabetic ketoacidosis.","volume":"372","author":"Kamel","year":"2015","journal-title":"N Engl J Med"},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41572-020-0165-1","article-title":"Diabetic ketoacidosis.","volume":"6","author":"Dhatariya","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1007\/s00134-018-5379-2","article-title":"Effectiveness of sodium bicarbonate infusion on mortality in septic patients with metabolic acidosis.","volume":"44","author":"Zhang","year":"2018","journal-title":"Intensive Care Med"},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1097\/CCM.0000000000003927","article-title":"Association between the use of sodium bicarbonate and mortality in acute kidney injury using marginal structural cox model.","volume":"47","author":"Zhang","year":"2019","journal-title":"Crit Care Med"},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)31080-8","article-title":"Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial.","volume":"392","author":"Jaber","year":"2018","journal-title":"Lancet"},{"key":"R7-20260519","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11892-017-0857-4","article-title":"Treatment of diabetic ketoacidosis (DKA)\/hyperglycemic hyperosmolar state (HHS): novel advances in the management of hyperglycemic crises (UK versus USA).","volume":"17","author":"Dhatariya","year":"2017","journal-title":"Curr Diab Rep"},{"key":"R8-20260519","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2110-5820-1-23","article-title":"Bicarbonate in diabetic ketoacidosis - a systematic review.","volume":"1","author":"Chua","year":"2011","journal-title":"Ann Intensive Care"},{"key":"R9-20260519","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset.","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci Data"},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","article-title":"The reporting of studies conducted using observational routinely-collected health Data (RECORD) statement.","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"R11-20260519","first-page":"1","article-title":"IPW: an R package for inverse probability weighting.","volume":"43","author":"Van der Wal","year":"2011","journal-title":"J Stat Softw"},{"key":"R12-20260519","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology.","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41419-023-05830-z","article-title":"Single-cell sequencing reveals homogeneity and heterogeneity of the cytopathological mechanisms in different etiology-induced AKI.","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis"},{"key":"R14-20260519","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2016.07.033","article-title":"Comparative effectiveness of 12 treatment strategies for preventing contrast-induced acute kidney injury: a systematic review and Bayesian network meta-analysis.","volume":"69","author":"Su","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit Care"},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/j.ajkd.2016.05.034","article-title":"Approach to the treatment of diabetic ketoacidosis.","volume":"68","author":"Kamel","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R17-20260519","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0002-9343(83)91203-2","article-title":"Sodium bicarbonate therapy in severe diabetic ketoacidosis.","volume":"75","author":"Lever","year":"1983","journal-title":"Am J Med"},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/0003-4819-105-6-836","article-title":"Bicarbonate therapy in severe diabetic ketoacidosis.","volume":"105","author":"Morris","year":"1986","journal-title":"Ann Intern Med"},{"key":"R19-20260519","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/bmj.289.6451.1035","article-title":"Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis.","volume":"289","author":"Hale","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R20-20260519","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13054-023-04587-3","article-title":"Identification of indications for albumin administration in septic patients with liver cirrhosis.","volume":"27","author":"Hu","year":"2023","journal-title":"Crit Care"},{"key":"R21-20260519","doi-asserted-by":"crossref","first-page":"105049","DOI":"10.1016\/j.ijmedinf.2023.105049","article-title":"Machine learning prediction models and nomogram to predict the risk of in-hospital death for severe DKA: a clinical study based on MIMIC-IV, eICU databases, and a college hospital ICU.","volume":"174","author":"Xie","year":"2023","journal-title":"Int J Med Inform"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:04:16Z","timestamp":1779195856000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047529","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2025-08-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}